These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3534742)

  • 21. Hepatic and serum ferritin concentrations in patients with idiopathic hemochromatosis.
    Beaumont C; Simon M; Smith PM; Worwood M
    Gastroenterology; 1980 Nov; 79(5 Pt 1):877-83. PubMed ID: 7419012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics and tissue penetration of ceftriaxone].
    Bergan T
    Rev Med Interne; 1985 Mar; 6(2):163-77. PubMed ID: 3890053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum bactericidal activity of ceftriaxone plus metronidazole against common intra-abdominal pathogens.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Quintiliani R
    Am J Hosp Pharm; 1994 Jul; 51(14):1782-7. PubMed ID: 7942906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
    Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P
    J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin) into cells of spleen, liver and kidney of mice.
    Kuhn H; Angehrn P; Havas L
    Chemotherapy; 1986; 32(2):102-12. PubMed ID: 3698722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatic disease associated with human immunodeficiency virus infection: anatomo-clinical study].
    Martínez P; González de Etxábarri S; Muñoz J; Santamaría JM; Ereño C; Miguel F
    Rev Esp Enferm Dig; 1994 May; 85(5):331-7. PubMed ID: 8049102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential depletion of carotenoids and tocopherol in liver disease.
    Leo MA; Rosman AS; Lieber CS
    Hepatology; 1993 Jun; 17(6):977-86. PubMed ID: 8514270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
    Goudah A; Shin HC; Shim JH; Abd El-Aty AM
    J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of ceftriaxone into the liver.
    Lucht F; Tigaud S; Brun M; Mahul P; Peyramond D; Bertrand JL
    J Antimicrob Chemother; 1986 Apr; 17(4):545-6. PubMed ID: 3710963
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.
    Suou T; Yamada S; Hosho K; Yoshikawa N; Kawasaki H
    Hepatology; 1996 May; 23(5):1154-8. PubMed ID: 8621148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does impairment of renal and hepatic function influence the metabolism of thrombolytics in patients with myocardial infarction?
    Vincze Z; Brugos B
    Pharmazie; 2008 Mar; 63(3):245-6. PubMed ID: 18444516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of hepatic vitamin E status in adult patients with liver disease.
    Nagita A; Ando M
    Hepatology; 1997 Aug; 26(2):392-7. PubMed ID: 9252150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of liver biopsy in the study of patients with fever of unknown origin (author's transl)].
    Bruguera M; Torres-Salinas M; Bordas JM; Bru C; Rodés J
    Med Clin (Barc); 1981 Jul; 77(3):115-7. PubMed ID: 7278421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
    De Marco A; Manca B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monotherapy with long half-life cephalosporins: example of ceftriaxone.
    Osborne JC
    Iowa Med; 1985 Oct; 75(10):460-6. PubMed ID: 4055303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.